Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: A cross sectional study

BMC Pregnancy and Childbirth

Volumn 8, Issue , 2008, Pages

  Rohra, Dileep K ^a   Das, Nirmal ^b   Azam, Syed I ^a   Solangi, Nazir A ^c   Memon, Zahida ^d   Shaikh, Abdul M ^e   Khan, Nusrat H ^f  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b BOLAN MEDICAL COLLEGE   (Pakistan)

^c Nawabshah Medical College   (Pakistan)

^d DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^e Chandka Medical College Hospital Shaheed Muhtarma Benazir Bhutto Medical University Larkana   (Pakistan)

^f DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTHELMINTIC AGENT; ANTIANEMIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIESTROGEN; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT; CARBAMAZEPINE; CARBIMAZOLE; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; ESTROGEN; IRON; METHOTREXATE; MINERAL; MISOPROSTOL; PHENYTOIN; PROGESTERONE; TERATOGENIC AGENT; UNINDEXED DRUG; VITAMIN; WARFARIN;

ARTICLE; CROSS-SECTIONAL STUDY; DRUG CLASSIFICATION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PAKISTAN; PREGNANCY; PRENATAL CARE; PRESCRIPTION; SECOND TRIMESTER PREGNANCY; TERATOGENICITY; TERTIARY HEALTH CARE; THIRD TRIMESTER PREGNANCY; VITAMIN SUPPLEMENTATION; ADULT; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG USE; MULTICENTER STUDY; STATISTICS; TEACHING HOSPITAL;

ADULT; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION REVIEW; FEMALE; HOSPITALS, TEACHING; HUMANS; PAKISTAN; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PREGNANCY TRIMESTERS; PRENATAL CARE; PRESCRIPTIONS, DRUG;

EID: 48649101310     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-8-24     Document Type: Article

References (19)

1. Benjamin DM Reducing medication errors and increasing patient safety: case studies in clinical pharmacology J Clin Pharmacol 2003, 43:768-783. 12856392
2. Kacew S Fetal consequences and risks attributed to the use of prescribed and over-the-counter (OTC) preparations during pregnancy Int J Clin Pharmacol Ther 1994, 32:335-243. 7952794
3. Koren G Pastuszak A Ito S Drugs in pregnancy N Eng J Med 1998, 338:1135-1137. 10.1056/NEJM199804163381607
4. De Jong-van den Berg LT Berg Van den PB Haaijer-Ruskamp FM Dukes MN Wesseling H Investigating drug use in pregnancy. Methodological problems and perspectives Pharm Weekbl Sci 1991, 13:32-38. 2034515
5. Beyens MN Guy C Ratrema M Ollagnier M Prescription of drugs to pregnant women in France: The HIMAGE study Therapie 2003, 58:505-511. 15058494
6. Medication during pregnancy: An intercontinental cooperative study. Collaborative Group on Drug Use in Pregnancy (C.G.D.U.P.) Int J Gynaecol Obstet 1992, 39:185-196. 10.1016/0020-7292(92)90656-4 1360913
7. Pakistan Drug Index Ready reference handbook of all medicines available in Pakistan 2007
8. Sharma R Kapoor B Verma U Drug utilization pattern during pregnancy in North India Indian J Med Sci 2006, 60:277-287. 16864912
9. Rockenbauer M Olsen J Czeizel AE Pedersen L Sørensen HT EuroMAP Group Recall bias in a case-control surveillance system on the use of medicine during pregnancy Epidemiology 2001, 12:461-466. 10.1097/ 00001648-200107000-00017 11416783
10. Sannerstedt R Lundborg P Danielsson BR Kihlström I Alván G Prame B Ridley E Drugs during pregnancy: An issue of risk classification and information to prescribers Drug Saf 1996, 14:69-77. 8852521
11. Lacroix I Damase-Michel C Lapeyre-Mestre M Montastruc JL Prescription of drugs during pregnancy in France Lancet 2000, 356:1735-1736. 10.1016/ S0140-6736(00)03209-8 11095263
12. Cooper WO Hickson GB Ray WA Prescriptions for contraindicated category X drugs in pregnancy among women enrolled in TennCare Paed Perinatal Eidemiol 2004, 18:106-111. 10.1111/j.1365-3016.2003.00542.x
13. Riley EH Fuentes-Afflick E Jackson RA Escobar GJ Brawarsky P Schreiber M Haas JS Correlates of prescription drug use during pregnancy J Women's Health 2005, 14:401-409. 10.1089/jwh.2005.14.401
14. Addis A Sharabi S Bonati M Risk classification systems for drug use during pregnancy: Are they a reliable source of information? Drug Saf 2000, 23:245-253. 10.2165/00002018-200023030-00006 11005706
15. Das B Sarkar C Datta A Bohra S A study of drug use during pregnancy in a teaching hospital in western Nepal Pharmacoepidemiol Drug Saf 2003, 12:221-225. 10.1002/pds.770 12733475
16. Glover DD Amonkar M Rybeck BF Tracy TS Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population Am J Obstet Gynecol 2003, 188:1039-1045. 10.1067/mob.2003.223 12712107
17. De Jong-van den Berg LT Berg Van den PB Haaijer-Ruskamp FM Dukes MN Wesseling H Investigating drug use in pregnancy. Methodological problems and perspectives Pharm Weekbl Sci 1991, 13:32-38. 2034515
18. Andrade SE Raebel MA Morse AN Davis RL Chan KA Finkelstein JA Fortman KK McPhillips H Roblin D Smith DH Yood MU Platt R H Gurwitz J Use of prescription medications with a potential for fetal harm among pregnant women Pharmacoepidemiol Drug Saf 2006, 15:546-554. 10.1002/pds.1235 16586470
19. Eadie MJ Antiepileptic drugs as human teratogens Expert Opin Drug Saf 2008, 7:195-209. 10.1517/14740338.7.2.195 18324882